Rob C. Hart is a Partner at Telegraph Hill Partners (THP), a venture capital firm focused on life science. See sector focus and contact routes.
Rob C. Hart is a Partner at Telegraph Hill Partners (THP), a venture capital firm focused on life science, medical devices, and healthcare, with a background spanning securities law, corporate finance, and investment banking since 1998[1][4]. THP’s investment thesis targets private life science and healthcare companies with validated technologies and solid customer bases, primarily in sectors like healthcare IT, diagnostics, and medical devices, often serving as the first institutional investor for boot-strapped firms[4]. The firm typically participates in growth equity rounds, though specific check sizes and lead/follow behavior are not publicly disclosed[4]. Hart represents THP on the boards of notable portfolio companies including EditCo, ETHERFAX, Frontier Psychiatry, InvisALERT, and Promptly, and has previously served on boards of acquired firms such as Nimble Therapeutics and Verogen[1]. As an angel investor, Hart also invests across biotech, healthcare, fintech, and health IT at various stages[2]. No distinctive public writing or unique point of view by Hart is documented in available sources.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Miami.
Investors like Rob C. Hart · Full investor directory · Investor access · Company funding database